<DOC>
	<DOCNO>NCT00367419</DOCNO>
	<brief_summary>We look effectiveness low-dose long-term prescription erythromycin mustard-induced bronchiolitis obliterans</brief_summary>
	<brief_title>Use Erythromycin Mustard-Induced Bronchiolitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<criteria>Documented chemical exposure Clinical , spirometric radiological finding compatible BO High Resolution Computed Tomography ( HRCT ) Nonresponsiveness high dose bronchodilator therapy Radiographic evidence pneumonia , active tuberculosis , lung carcinoma , infection necessitate use antibiotic History cigarette smoke occupational exposure toxic agent hypersensitivity macrolides History treatment systemic antibiotic within 7 day start study Any investigational medicine within 4 week study History antibiotic injection within 6 week study Concomitant Theophylline Carbamazepine , unless serum concentration regularly monitor Patients exacerbation phase respiratory complication Need use medication interact macrolides Digoxin , Theophylline Carbamazepine Systemic antibiotic Systemic Corticosteroids Admission hospital Abnormal kidney liver function</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
</DOC>